Malignant Tumour Clinical Trials

1 recruiting

About Malignant Tumour Clinical Trials

Looking for clinical trials for Malignant Tumour? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Malignant Tumour trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Malignant Tumour clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Early Phase 1

A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening

Advanced Malignant Tumours
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT07395479
Recruiting
Phase 2

A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour

Advanced Malignant Tumour
Shandong Suncadia Medicine Co., Ltd.300 enrolled2 locationsNCT06915142
Recruiting
Phase 1

A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour

Advanced Malignant Tumour
Shandong Suncadia Medicine Co., Ltd.233 enrolled1 locationNCT06383871
Recruiting
Early Phase 1

Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

Malignant Tumour
First Affiliated Hospital of Fujian Medical University30 enrolled1 locationNCT06995976
Recruiting
Phase 1

Clinical Trial to Evaluate the Tolerance of TQB2210 Injection

Advanced Malignant Tumours
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.90 enrolled7 locationsNCT06929195
Recruiting

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

Gastric CancersEsophageal CancerCancer Screening+14 more
Second Affiliated Hospital, School of Medicine, Zhejiang University600 enrolled4 locationsNCT06822413
Recruiting

Validation of the O-bridge Protocol: a Prospective, Multicenter Trial

Quality of LifeMandibular ReconstructionBenign or Malignant Tumour of the Oral Cavity+2 more
AZ Sint-Jan AV80 enrolled5 locationsNCT04007783